Pluri (PLUR) Net Income (2010 - 2025)
Pluri (PLUR) posted quarterly Net Income of -$6.9 million for Q4 2025, down 120.96% year-over-year from $32.8 million in Q4 2024, and down 12.07% quarter-over-quarter from -$6.1 million in Q3 2025.
Pluri (PLUR) Net Income (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Net Income for 16 consecutive years, with -$6.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Income fell 120.96% year-over-year to -$6.9 million; the TTM figure through Dec 2025 stood at -$25.5 million (down 19.45% YoY), while the FY2025 annual figure was -$23.2 million, down 8.93% from the prior year.
- Net Income retreated to -$6.9 million in Q4 2025 per PLUR's latest filing, from -$6.1 million in the prior quarter.
- Across five years, Net Income topped out at -$3.1 million in Q4 2024 and bottomed at -$14.6 million in Q2 2021.
- Historically, Net Income has averaged -$7.9 million across 5 years, with a median of -$6.7 million in 2022.
- Annual changes were most pronounced in 2022 — Net Income surged 44.57% — and 2025, when it tumbled 120.96%.
- Pluri's Net Income stood at -$11.2 million in 2021, then grew by 24.17% to -$8.5 million in 2022, then surged by 35.87% to -$5.4 million in 2023, then surged by 42.72% to -$3.1 million in 2024, then plunged by 120.96% to -$6.9 million in 2025.
- Business Quant data shows PLUR's Net Income at -$6.9 million in Q4 2025, -$6.1 million in Q3 2025, and -$6.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -6.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.87 Mn |
| Sep 30, 2025 | -6.13 Mn |
| Jun 30, 2025 | -6.85 Mn |
| Mar 31, 2025 | -5.61 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -6.04 Mn |
| Jun 30, 2024 | -6.25 Mn |
| Mar 31, 2024 | -5.92 Mn |
| Dec 31, 2023 | -5.43 Mn |
| Sep 30, 2023 | -5.59 Mn |
| Jun 30, 2023 | -5.98 Mn |
| Mar 31, 2023 | -7.98 Mn |
| Dec 31, 2022 | -8.47 Mn |
| Sep 30, 2022 | -6.46 Mn |
| Jun 30, 2022 | -9.17 Mn |
| Mar 31, 2022 | -10.14 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -11.66 Mn |
| Jun 30, 2021 | -14.65 Mn |
| Mar 31, 2021 | -14.44 Mn |